RU2420279C3 - Применение ингибиторов hdac для лечения миеломы - Google Patents

Применение ингибиторов hdac для лечения миеломы

Info

Publication number: RU2420279C3
Authority: RU; Russia
Prior art keywords: application; hdac inhibitors; treat myeloma; myeloma; treat
Prior art date: 2005-08-03

Application number

RU2008107871A

Other languages

English (en)

Other versions

RU2420279C2 (ru

RU2008107871A (ru

Original Assignee

Новартис Аг

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-03

Filing date

2006-08-01

Publication date

2017-03-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37307336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2420279(C3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-08-01 Application filed by Новартис Аг filed Critical Новартис Аг

2009-09-10 Publication of RU2008107871A publication Critical patent/RU2008107871A/ru

2011-06-10 Application granted granted Critical

2011-06-10 Publication of RU2420279C2 publication Critical patent/RU2420279C2/ru

2017-03-14 Publication of RU2420279C3 publication Critical patent/RU2420279C3/ru

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

RU2008107871A 2005-08-03 2006-08-01 Применение ингибиторов hdac для лечения миеломы RU2420279C3 (ru)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70522605P	2005-08-03	2005-08-03
US60/705,226		2005-08-03

Publications (3)

Publication Number	Publication Date
RU2008107871A RU2008107871A (ru)	2009-09-10
RU2420279C2 RU2420279C2 (ru)	2011-06-10
RU2420279C3 true RU2420279C3 (ru)	2017-03-14

Family

ID=37307336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2008107871A RU2420279C3 (ru)	2005-08-03	2006-08-01	Применение ингибиторов hdac для лечения миеломы

Country Status (18)

Country	Link
US (2)	US20080221126A1 (ru)
EP (1)	EP1912640B1 (ru)
JP (2)	JP5665271B2 (ru)
KR (1)	KR101354237B1 (ru)
CN (2)	CN101232880A (ru)
AU (1)	AU2006278718B2 (ru)
BR (1)	BRPI0614090A2 (ru)
CA (1)	CA2617274C (ru)
DK (1)	DK1912640T3 (ru)
ES (1)	ES2545076T3 (ru)
HU (1)	HUE028025T2 (ru)
LT (1)	LTC1912640I2 (ru)
MX (1)	MX2008001610A (ru)
PL (1)	PL1912640T3 (ru)
PT (1)	PT1912640E (ru)
RU (1)	RU2420279C3 (ru)
SI (1)	SI1912640T1 (ru)
WO (1)	WO2007019116A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0614090A2 (pt) *	2005-08-03	2011-03-09	Novartis Ag	uso de inibidores da hdac para o tratamento do mieloma
EP2491923A3 (en) *	2007-02-15	2012-12-26	Novartis AG	Combinations of therapeutic agents for treating cancer
WO2008150782A1 (en) *	2007-05-30	2008-12-11	Novartis Ag	Use of hdac inhibitors for the treatment of bone destruction
US20120046242A1 (en) *	2008-12-24	2012-02-23	Massachusetts Institute Of Technology	Molecular activators of the wnt/beta-catenin pathway
CA2780772C (en) †	2009-11-13	2018-01-16	Receptos, Inc.	Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
RU2013114246A (ru) *	2010-09-01	2014-10-20	Новартис Аг	Комбинация hdac ингибиторов с лекарственными средствами против тромбоцитопении
MA41544A (fr) *	2015-02-19	2017-12-26	Novartis Ag	Dosages de panobinostat pour le traitement du myélome multiple
JP6923219B2 (ja)	2015-11-03	2021-08-18	ホーホシューレダルムシュタット	選択的ｈｄａｃ８阻害剤およびこれらの使用
CN105348169B (zh) *	2015-11-16	2018-03-30	青岛大学	一种组蛋白去乙酰酶抑制剂(e)‑3‑(2‑(1‑(4‑氯苯甲酰基)‑5‑甲氧基‑2‑甲基‑1氢‑吲哚‑3‑基)乙酰氨基)‑n‑羟基丁‑2‑烯酰胺及其制备方法和应用
CN109705057B (zh) *	2017-10-25	2023-05-30	成都先导药物开发股份有限公司	组蛋白去乙酰化酶抑制剂及其制备方法与用途
US10537585B2 (en)	2017-12-18	2020-01-21	Dexcel Pharma Technologies Ltd.	Compositions comprising dexamethasone
CN113164375A (zh)	2018-07-18	2021-07-23	希成生物医药	包含盐霉素的聚合物纳米颗粒
WO2022251844A1 (en)	2021-05-25	2022-12-01	Hillstream Biopharma, Inc.	Polymeric nanoparticles comprising chemotherapeutic compounds and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20020354A1 (es) *	2000-09-01	2002-06-12	Novartis Ag	Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
PT1392313E (pt) *	2001-05-16	2007-07-17	Novartis Ag	Combinação que compreende n - ( 5- [ 4- ( metil-piperazinomrtil ) - benxoilamido ] - 2 -metilfenil ) - 4 -( 3 - piridil ) - 2 - pirimidina-amina e um agente quimioterapêutico
US20050227300A1 (en)	2001-12-07	2005-10-13	Atadja Peter W	Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors
US20040132825A1 (en) *	2002-03-04	2004-07-08	Bacopoulos Nicholas G.	Methods of treating cancer with HDAC inhibitors
US20050043233A1 (en)	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
CN1791396A (zh) *	2003-05-21	2006-06-21	诺瓦提斯公司	组蛋白脱乙酰基酶抑制剂与化疗剂的组合
CN1964714B (zh)	2003-08-29	2011-09-28	Hdac默克研究有限责任公司	辛二酰苯胺异羟肟酸和吉西他滨在制备用于治疗癌症的药物中的用途
CA2601706C (en)	2005-03-22	2016-09-20	Dana-Farber Cancer Institute, Inc.	Treatment of protein degradation disorders
BRPI0614090A2 (pt) *	2005-08-03	2011-03-09	Novartis Ag	uso de inibidores da hdac para o tratamento do mieloma

2006
- 2006-08-01 BR BRPI0614090-4A patent/BRPI0614090A2/pt not_active Application Discontinuation
- 2006-08-01 ES ES06789025.1T patent/ES2545076T3/es active Active
- 2006-08-01 US US11/996,323 patent/US20080221126A1/en not_active Abandoned
- 2006-08-01 CN CNA2006800281244A patent/CN101232880A/zh active Pending
- 2006-08-01 HU HUE06789025A patent/HUE028025T2/en unknown
- 2006-08-01 SI SI200631952T patent/SI1912640T1/sl unknown
- 2006-08-01 RU RU2008107871A patent/RU2420279C3/ru not_active IP Right Cessation
- 2006-08-01 JP JP2008525092A patent/JP5665271B2/ja active Active
- 2006-08-01 MX MX2008001610A patent/MX2008001610A/es active IP Right Grant
- 2006-08-01 AU AU2006278718A patent/AU2006278718B2/en not_active Ceased
- 2006-08-01 CA CA2617274A patent/CA2617274C/en active Active
- 2006-08-01 EP EP06789025.1A patent/EP1912640B1/en active Active
- 2006-08-01 PT PT67890251T patent/PT1912640E/pt unknown
- 2006-08-01 PL PL06789025T patent/PL1912640T3/pl unknown
- 2006-08-01 KR KR1020087002803A patent/KR101354237B1/ko not_active Expired - Fee Related
- 2006-08-01 CN CN201410610419.9A patent/CN104324025A/zh active Pending
- 2006-08-01 WO PCT/US2006/029801 patent/WO2007019116A1/en not_active Ceased
- 2006-08-01 DK DK06789025.1T patent/DK1912640T3/en active
2010
- 2010-03-04 US US12/717,373 patent/US8883842B2/en active Active
2013
- 2013-04-04 JP JP2013078867A patent/JP5876435B2/ja active Active
2016
- 2016-01-22 LT LTPA2016003C patent/LTC1912640I2/lt unknown

Also Published As

Publication number	Publication date
CA2617274A1 (en)	2007-02-15
JP5876435B2 (ja)	2016-03-02
US20080221126A1 (en)	2008-09-11
EP1912640B1 (en)	2015-06-17
CA2617274C (en)	2017-10-10
KR101354237B1 (ko)	2014-01-22
SI1912640T1 (sl)	2015-10-30
JP2009503087A (ja)	2009-01-29
WO2007019116A1 (en)	2007-02-15
JP2013173757A (ja)	2013-09-05
US8883842B2 (en)	2014-11-11
KR20080031937A (ko)	2008-04-11
CN101232880A (zh)	2008-07-30
DK1912640T3 (en)	2015-09-14
JP5665271B2 (ja)	2015-02-04
MX2008001610A (es)	2008-02-19
RU2420279C2 (ru)	2011-06-10
RU2008107871A (ru)	2009-09-10
PL1912640T3 (pl)	2015-11-30
PT1912640E (pt)	2015-09-22
AU2006278718A1 (en)	2007-02-15
US20100160257A1 (en)	2010-06-24
AU2006278718B2 (en)	2010-10-07
BRPI0614090A2 (pt)	2011-03-09
HUE028025T2 (en)	2016-11-28
LTC1912640I2 (lt)	2017-09-11
ES2545076T3 (es)	2015-09-08
CN104324025A (zh)	2015-02-04
EP1912640A1 (en)	2008-04-23

Publication	Publication Date	Title
DK1940839T3 (da)	2013-10-14	Pyridopyrimidione Inhibitors of P13Ka
LTC1912640I2 (lt)	2017-09-11	HDAC inhibitoriaus panobinostato panaudojimas mielomos gydymui
CY2017044I2 (el)	2018-09-05	Αντισωματα εναντι cd38 για τη θεραπεια του πολλαπλου μυελωματος
ATE543816T1 (de)	2012-02-15	Azacycloalkanderivate als inhibitoren von stearoyl-coenzym-a-delta-9-desaturase
BRPI0719204A2 (pt)	2014-03-04	Inibidores de hdac
SMT201700036B (it)	2017-03-08	Composti e composizioni come inibitori di protein chinasi
SMAP200900058A (it)	2010-01-19	Composti e composizioni come inibitori di proteinachinasi
SM201000108B (it)	2012-01-18	Composti e composizioni come inibitori di proteinachinasi
SMAP200900020A (it)	2009-05-11	Composti e composizioni come inibitori di proteinachinasi
SMAP200900031A (it)	2009-07-14	Composti e composizioni come inibitori di proteinachinasi
HRP20150003T1 (xx)	2015-03-13	Sastavi inhibitora dpp-iv
ZA200801394B (en)	2009-12-30	Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles
EP2049505A4 (en)	2010-12-22	ISOFORM SELECTIVE HDAC HEMMER
DK1898903T3 (da)	2013-07-01	Inhibitorer af Akt-aktivitet
EP2303269A4 (en)	2011-09-28	HAMMER OF ACT ACTIVITY
EP2272817A4 (en)	2011-12-14	PAI-1 INHIBITORS
BRPI0717460A2 (pt)	2013-12-24	Composições de inibidores de chk1
EP2036552A4 (en)	2009-11-04	SENESCENCE INHIBITOR
EP2192838A4 (en)	2011-07-27	HETEROCYCLIC NEKROPTOSIS HEMMER
EP1991226A4 (en)	2012-01-25	Histone deacetylase INHIBITORS
EP2007383A4 (en)	2010-09-15	HEMMER OF PROTEIN PRENYL TRANSFERASES
EP2010168A4 (en)	2011-06-01	Histone deacetylase INHIBITORS
EP2299825A4 (en)	2011-06-01	HAMMER OF ACT ACTIVITY
EP2139883A4 (en)	2011-06-22	HIV-1 protease inhibitor
EP2229363A4 (en)	2010-12-15	Renin Inhibitors

Legal Events

Date	Code	Title	Description
2017-03-14	ND4A	Extension of patent duration	Effective date: 20170314
2020-07-23	PC41	Official registration of the transfer of exclusive right	Effective date: 20200723
2021-05-12	MM4A	The patent is invalid due to non-payment of fees	Effective date: 20200802